Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 267 publications
Clinicopathological features and management of IgM multiple myeloma and Waldenstrom macroglobulinemia.
Journal: Leukemia & lymphoma
Published: January 22, 2026
WNK2 oncogenicity revealed by the discovery and functional characterization of novel gene isoforms in MYD88 mutated Waldenström's Macroglobulinemia.
Journal: Blood cancer journal
Published: January 20, 2026
Discovery and Characterization of a First-In-Class HCK/BTK PROTAC DFCI-002-06 for the Treatment of MYD88 Mutated B Cell Malignancies.
Journal: Journal of medicinal chemistry
Published: January 03, 2026
Venetoclax or Pirtobrutinib in Relapsed/Refractory Waldenström Macroglobulinemia: Clinical and Molecular Predictors and Sequencing Implications.
Journal: American journal of hematology
Published: December 29, 2025
Final Report of a Phase II Study of Ibrutinib and Venetoclax in Previously Untreated Waldenström Macroglobulinemia.
Journal: American journal of hematology
Published: November 10, 2025
Safety and activity of pirtobrutinib in patients with relapsed or refractory Waldenström macroglobulinaemia: 5-year follow-up of the open-label, multicentre, phase 1/2 BRUIN trial.
Journal: The Lancet. Haematology
Published: September 18, 2025
Distinct molecular subtypes in Waldenström macroglobulinemia.
Journal: Blood
Published: September 04, 2025
Last Updated: 09/26/2026